The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

Objective We analysed the pharmacokinetics of meropenem and piperacillin-tazobactam in patients undergoing a standardised session of sustained low efficiency haemodiafiltration (SLED-HDF) to inform the dosing of these drugs in an acute setting. Participants Six stable patients with end-stage kidney...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2020-02, Vol.76 (2), p.239-247
Hauptverfasser:	Donnellan, Sine, Wright, Daniel F. B., Roberts, Jason A., Duffull, Stephen B., Schollum, John B. W., Putt, Tracey L., Wallis, Steven C., Walker, Robert J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Biomedical and Life Sciences Biomedicine Clinical trials End-stage renal disease Kidney diseases Meropenem Minimum inhibitory concentration Pathogens Pharmacokinetics Pharmacokinetics and Disposition Pharmacology/Toxicology Piperacillin Piperacillin-tazobactam Sleds Tazobactam
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!